Abstract:ABSTRACT Naringenin is the central flavonoid in the biosynthesis of several bioactive compounds and presents a growing demand for its nutraceutical properties. Naringenin extraction from plants is non-viable due to low yields, and microbial platforms could represent a controlled and sustained alternative to produce it using several metabolic engineering tools. This study shows the naringenin production in Saccharomyces cerevisiae from glucose through a combined approach of systems biology, enzyme criteria selection, and a molecular engineering strategy. In silico prediction using a mixed integer linear programming (MILP) algorithm showed that the phenylpropanoid pathway was the shortest and most viable metabolic pathway. Two biscistronic constructs were generated using the PTV-1 2A peptide sequence, and a naringenin biofactory was assembled with the phenylalanine ammonia-lyase/tyrosine ammonia-lyase genes encoding phenylalanine/tyrosine ammonia-lyase ( Rhodobacter capsulatus ), 4-coumaroyl (4 Cl) encoding a p -coumaroyl-CoA ligase ( Solanum lycopersicum ), CHS encoding chalcone synthase ( Hypericum androsaemum ), and CHI encoding a chalcone isomerase ( Glycine max ). Naringenin productivity in batch fermentation was about 40.67 ± 3.47 μg/Lh with a 6.10 ± 0.52 mg/L titer (22.41 ± 1.91 μM) and a 3.26 ± 1.36 mg/g yield ( Y P / S ) with the detection of additional flavonoids. The obtained concentration is better than other related works in diverse engineered microorganisms. The results suggest a successful and optimizable alternative for the heterologous flavanone production in yeast combined with bicistronic expression mediated by a 2A peptide sequence for the first time. This strategy supports the production of extensive routes for other nutraceutical compounds. IMPORTANCE Flavonoids are a group of compounds generally produced by plants with proven biological activity, which have recently beeen recommended for the treatment and prevention of diseases and ailments with diverse causes. In this study, naringenin was produced in adequate amounts in yeast after in silico design. The four genes of the involved enzymes from several organisms (bacteria and plants) were multi-expressed in two vectors carrying each two genes linked by a short viral peptide sequence. The batch kinetic behavior of the product, substrate, and biomass was described at lab scale. The engineered strain might be used in a more affordable and viable bioprocess for industrial naringenin procurement.

Activation of Naringenin and Kaempferol through Pathway Refactoring in the Endophyte Phomopsis Liquidambaris

Modular Optimization of Heterologous Pathways for De Novo Synthesis of (2S)-Naringenin in Escherichia coli

Optimizing yeast for high-level production of kaempferol and quercetin

Expanding flavone and flavonol production capabilities in Escherichia coli

Modulating heterologous pathways and optimizing fermentation conditions for biosynthesis of kaempferol and astragalin from naringenin in Escherichia coli

Promoter-Library-Based Pathway Optimization for Efficient (2 S)-Naringenin Production from p-Coumaric Acid in Saccharomyces cerevisiae

Fermentation and Metabolic Pathway Optimization to De Novo Synthesize (2S)-Naringenin in Escherichia coli

Optimizing Oleaginous Yeast Cell Factories for Flavonoids and Hydroxylated Flavonoids Biosynthesis

De Novo Production of Plant 4′-Deoxyflavones Baicalein and Oroxylin A from Ethanol in Crabtree-Negative Yeast

Promoter Activation in Δhfq Mutants As an Efficient Tool for Specialized Metabolite Production Enabling Direct Bioactivity Testing.

Riboswitch-guided chalcone synthase engineering and metabolic flux optimization for enhanced production of flavonoids

Discovery and Validation of a Novel Step Catalyzed by OsF3H in the Flavonoid Biosynthesis Pathway

Saccharomyces cerevisiae biofactory to produce naringenin using a systems biology approach and a bicistronic vector expression strategy in flavonoid production

Transcriptional and translational flux optimization at the key regulatory node for enhanced production of naringenin using acetate in engineered Escherichia coli

Effects of metabolic pathway gene copy numbers on the biosynthesis of (2S)-naringenin in Saccharomyces cerevisiae

A Plug‐and‐play Pathway Refactoring Workflow for Natural Product Research in Escherichia Coli and Saccharomyces Cerevisiae

Fine-tuning of coumaric acid synthesis to increase naringenin production in yeast

Elucidation of the biosynthesis pathway and heterologous construction of a sustainable route for producing umbelliferone

Stepwise engineering of Saccharomyces cerevisiae to produce (+)-valencene and its related sesquiterpenes

Combinatorial biosynthesis of flavones and flavonols in Escherichia coli

Systematically Engineered Fatty Acid Catabolite Pathway for the Production of (2 S )-Naringenin in Saccharomyces cerevisiae